Home > Balance Sheet > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Total Non-Current Liabilities

    Back to Balance Sheet
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Non-Current Liabilities ₹144 Cr₹111 Cr₹108 Cr₹125 Cr₹159 Cr

What is the latest Total Non-Current Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Total Non-Current Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹144 Cr based on Mar2026 Consolidated results.
Year Total Non-Current Liabilities
Mar2026₹144 Cr
Mar2025₹111 Cr
Mar2024₹108 Cr
Mar2023₹125 Cr
Mar2022₹159 Cr

How is Total Non-Current Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Total Non-Current Liabilities % Change
Mar2026 ₹144 Cr
29.59
Mar2025 ₹111 Cr
2.80
Mar2024 ₹108 Cr
-14.10
Mar2023 ₹125 Cr
-21.01
Mar2022 ₹159 Cr -

Compare Total Non-Current Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹44,874.1 Cr -2.3% 5% 7.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,944.0 Cr -2% 6% 9.6% Stock Analytics
DIVIS LABORATORIES ₹294,962.0 Cr -4% 22.9% 75.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹178,391.0 Cr -1.8% 1.8% 21.9% Stock Analytics
DR REDDYS LABORATORIES ₹115,267.0 Cr -0.4% 13.1% 13.7% Stock Analytics
CIPLA ₹112,620.0 Cr -0.9% 4.5% -8% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-2.3%

5%

7.8%

SENSEX

1.4%

12.8%

-1.7%


You may also like the below Video Courses